AYUSH Advertising Regulations Tightened Following Supreme Court Decision
Friday, 6 September 2024, 20:51
Increased Scrutiny of AYUSH Advertising
The Kerala drugs control department is responding to the Supreme Court's recent ruling by tightening the scrutiny of advertisements for Ayurveda, Siddha, and Unani products. This development aims to protect consumers from misleading claims and ensure that all marketed products adhere to established guidelines.
Regulatory Implications
- This decision underscores the importance of regulatory compliance in the AYUSH sector.
- Companies involved in advertising must now provide clearer, evidential claims regarding their products.
- The ruling emphasizes the need for transparency in the marketing of alternative medicine.
Healthcare professionals and organizations are encouraged to stay informed about these changes to enhance patient safety and promote ethical marketing practices in the AYUSH domain.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.